CD19 and B-cell non-Hodgkin lymphoma: Mostly well-known CAR-T cell is CD19-targeted one which recognize the CD19 on B cell lymphoma and destroyed them successfully in clinical trial (Brentjens et al. 2013; Davila et al. 2014; Lee et al. 2015).